US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease

reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-fortress-bio-zydus-treatment-rare-pediatric-disease-2025-10-01

This story appeared on reuters.com, 2025-10-01 12:17:12.178000.
The Entire Business World on a Single Page. Free to Use →